Terms: = Ovarian cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
76 results:
1. Transformer 2β regulates the alternative splicing of cell cycle regulatory genes to promote the malignant phenotype of ovarian cancer.
Zhou T; Fu P; Chen D; Liu R
Oncol Res; 2023; 31(5):769-785. PubMed ID: 37547760
[TBL] [Abstract] [Full Text] [Related]
2. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Kast K; John EM; Hopper JL; Andrieu N; Noguès C; Mouret-Fourme E; Lasset C; Fricker JP; Berthet P; Mari V; Salle L; Schmidt MK; Ausems MGEM; Garcia EBG; van de Beek I; Wevers MR; Evans DG; Tischkowitz M; Lalloo F; Cook J; Izatt L; Tripathi V; Snape K; Musgrave H; Sharif S; Murray J; ; Colonna SV; Andrulis IL; Daly MB; Southey MC; de la Hoya M; Osorio A; Foretova L; Berkova D; Gerdes AM; Olah E; Jakubowska A; Singer CF; Tan Y; Augustinsson A; Rantala J; Simard J; Schmutzler RK; Milne RL; Phillips KA; Terry MB; Goldgar D; van Leeuwen FE; Mooij TM; Antoniou AC; Easton DF; Rookus MA; Engel C
Breast Cancer Res; 2023 Jun; 25(1):72. PubMed ID: 37340476
[TBL] [Abstract] [Full Text] [Related]
3. liposomal DQ in Combination with Copper Inhibits ARID1A Mutant ovarian cancer Growth.
Kang X; Wang Q; Wu S; Wang C; Annaji M; Huang CH; Shen J; Chen P; Babu RJ
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238613
[TBL] [Abstract] [Full Text] [Related]
4. miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting hmga2.
Song Z; Liao C; Yao L; Xu X; Shen X; Tian S; Wang S; Xing F
Cancer Gene Ther; 2023 Apr; 30(4):596-607. PubMed ID: 36494581
[TBL] [Abstract] [Full Text] [Related]
5. Mathematical Modeling and Experimental Validation of Extracellular Vesicle-Mediated Tumor Suppressor MicroRNA Delivery and Propagation in ovarian cancer Cells.
Gandham SK; Attarwala HZ; Amiji MM
Mol Pharm; 2022 Nov; 19(11):4067-4079. PubMed ID: 36226722
[TBL] [Abstract] [Full Text] [Related]
6. Preparation and In Vitro Evaluation of Thermosensitive liposomes Targeting ovarian cancer.
Wang X; Wang F; Li S; Yin G; Pu X
Curr Drug Deliv; 2022 Aug; 19(9):940-948. PubMed ID: 35319368
[TBL] [Abstract] [Full Text] [Related]
7. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic hmga2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract] [Full Text] [Related]
8. circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/hmga2 axis.
Ma W; Xue N; Zhang J; Wang D; Yao X; Lin L; Xu Q
Int J Oncol; 2021 Mar; 58(3):298-311. PubMed ID: 33650644
[TBL] [Abstract] [Full Text] [Related]
9. Role of M2-like macrophages in the progression of ovarian cancer.
Baek SH; Lee HW; Gangadaran P; Oh JM; Zhu L; Rajendran RL; Lee J; Ahn BC
Exp Cell Res; 2020 Oct; 395(2):112211. PubMed ID: 32755554
[TBL] [Abstract] [Full Text] [Related]
10. Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer.
Irvin S; Clarke MA; Trabert B; Wentzensen N
Cancer Causes Control; 2020 Oct; 31(10):869-879. PubMed ID: 32685996
[TBL] [Abstract] [Full Text] [Related]
11. Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery
Guo L; Zhang Y; Wei R; Zhang X; Wang C; Feng M
Theranostics; 2020; 10(15):6581-6598. PubMed ID: 32550891
[No Abstract] [Full Text] [Related]
12. Lipid profile and risk of ovarian tumours: a meta-analysis.
Onwuka JU; Okekunle AP; Olutola OM; Akpa OM; Feng R
BMC Cancer; 2020 Mar; 20(1):200. PubMed ID: 32164586
[TBL] [Abstract] [Full Text] [Related]
13. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
[TBL] [Abstract] [Full Text] [Related]
14. MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC.
Sun C; Cao W; Qiu C; Li C; Dongol S; Zhang Z; Dong R; Song K; Yang X; Zhang Q; Kong B
J Hematol Oncol; 2020 Jan; 13(1):9. PubMed ID: 32005272
[TBL] [Abstract] [Full Text] [Related]
15. Regulation of hmga2 and KRAS genes in epithelial ovarian cancer by miRNA hsa-let-7d-3p.
Gunel T; Dogan B; Gumusoglu E; Hosseini MK; Topuz S; Aydinli K
J Cancer Res Ther; 2019; 15(6):1321-1327. PubMed ID: 31898667
[TBL] [Abstract] [Full Text] [Related]
16. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177
[TBL] [Abstract] [Full Text] [Related]
17. BRCA1 regulates hmga2 levels in the Swan71 trophoblast cell line.
West RC; Russ JE; Bouma GJ; Winger QA
Mol Reprod Dev; 2019 Nov; 86(11):1663-1670. PubMed ID: 31410930
[TBL] [Abstract] [Full Text] [Related]
18. Overexpression of
Palumbo Júnior A; de Sousa VPL; Esposito F; De Martino M; Forzati F; Moreira FCB; Simão TA; Nasciutti LE; Fusco A; Ribeiro Pinto LF; Bessa Pereira Chaves C; Meireles Da Costa N
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31096664
[TBL] [Abstract] [Full Text] [Related]
19. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by hmga2-mediated epithelial-mesenchymal transition.
Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D
Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010
[TBL] [Abstract] [Full Text] [Related]
20. Tunneling Nanotubular Expressways for Ultrafast and Accurate M1 Macrophage Delivery of Anticancer Drugs to Metastatic ovarian Carcinoma.
Guo L; Zhang Y; Yang Z; Peng H; Wei R; Wang C; Feng M
ACS Nano; 2019 Feb; 13(2):1078-1096. PubMed ID: 30608136
[TBL] [Abstract] [Full Text] [Related]
[Next]
